- In May 2023, Smith+Nephew received an innovative technology contract for its PICO Single Use Negative Pressure Wound Therapy Systems from Vizient, Inc. This contract will strengthen research and development related to NPWT, thereby driving market growth
- In April 2023, Convatec Group PLC acquired 30 Technology Limited’s anti-infective nitric oxide technology platform, which includes new product assets and R&D. In addition to enhanced wound care, Convatec plans to explore the technical platform for use in other businesses
- In August 2023, Medela launched novel Invia Integrated Dressing for different types of wound
- In January 2022, Smith+Nephew announced that the FDA cleared its Single Use Negative Pressure Wound Therapy (sNPWT) Systems PICO 7 and PICO 14 for new indications in closed surgical incisions, which can help lower the occurrence of dehiscence, postoperative seroma, and superficial and deep incisional Surgical Site Infections (SSIs)
- In March 2022, Cardinal Health announced the first surgical incise drape launch using chlorhexidine gluconate (CHG). Cardinal Health believes this new drape can improve patient care by reducing the risk of microbial contamination.
